Abiopharma

🔍 Eldessouky Sam (Executive)

Company: Bausch & Lomb Corp (BLCO)

Report Date: 2026-03-06

Detailed Transactions and Holdings:

• Acquired 4,000 shares of Common Shares, No Par Value at $17.13 per share (Direct)
  Date: 2026-03-06 | Code: P | equity_swap_involved: 0 | shares_owned_after: 403,130.00 | transaction_form_type: 4
• Acquired 4,000 shares of Common Shares, No Par Value (Direct)
  Date: 2026-03-06 | Code: A | equity_swap_involved: 0 | shares_owned_after: 407,130.00 | transaction_form_type: 4 | Footnotes: F1

Footnotes:

• F1: Represents matching restricted share units ("MRSUs") granted to the reporting person in connection with the open market purchase of common shares reported on Table I above, pursuant to the issuer's matching share program. One-third of the MRSUs will vest on each of the first, second, and third anniversaries following the date of grant, subject to the reporting person's continued service (except in limited circumstances).